Mark the 2022 Prostate Cancer Awareness Month with Dr. Michael Lutz, president of the MIU Men’s Health Foundation, and prostate cancer survivor and former Navy pilot, Craig Reiner, as they discuss the current state of diagnosis and treatment as well as the many changes that have taken place in understanding this disease since Prostate Cancer Awareness month was first established in 1999 and designated as National Prostate Cancer Awareness Month in 2003. Go here for “Flying High.” This podcast is brought to you in part by BlueEarth Diagnostics.
Thanks to MPCC board members Allen Snyder and Analesa Baraka who join MPCC Medical Advisory Committee member Dr. Quoc -Dien Trinh in discussing “Shared Decision Making: Then and Now.” This podcast includes an interview with MPCC chairman Allen Snyder who shares his story on being diagnosed with prostate cancer nearly 25 years ago,. He is followed by Dr. Trinh of Brigham and Women’s Prostate Cancer Program who discusses how the Prostate Cancer Workgroup, part of the MDPH Comprehensive Cancer Prevention and Control Network, has contributed to the progress and evolution of shared decision making. The podcast concludes with Analesa Baraka, NP, describing the important role of the nurse practitioner in coordinating the decision making of process of men diagnosed with this disease. Thanks also to Blue Earth Diagnostics for its support of this podcast.
Join Dr. Adam Kibel, Clare Tempany, J. Jacques Carter, Richard Babayan, and Glenn Bubley as they reflect on the advances in prostate cancer diagnosis, treatment and research since the Jack Colbert Memorial Award was established by MPCC in 2008. The Colbert Award is presented periodically, at the discretion of the MPCC board of directors, to a distinguished individual in the medical community who has significantly advanced the fight to conquer and cure prostate cancer. Dr. Kibel, the 2021 recipient of this award, was recognized at a November reception at the Harvard Club in Boston.
Thanks to David Einstein, MD, from Beth Israel Deaconess Medical Center, for discussing “Into the Unknown: How Do We Study Prostate Cancer Treatments, ” For every exciting new therapy, there is a long road of research along which many other strategies have been abandoned. In this podcast, Dr. Einstein outlines the process of identifying new treatment strategies in the lab, “translating” these into clinical trials, and developing them into standard-of-care treatments. Dr. Einstein will explore this topic in more detail on the May 14 virtual symposium, hosted by MPCC. Click here to learn more about the Massachusetts Prostate Cancer Coalition.
Thanks to Christina Dieli-Conwright, PhD, MPH, Dana-Farber Cancer Institute for discussing “Exercise as Medicine for Prostate Cancer Survivorship.” Persons at risk and diagnosed with prostate cancer are a vulnerable population in need of non-pharmacologic interventions to improve health outcomes. Using an “Exercise as Medicine” approach, intervention studies demonstrate that exercise can improve comorbid conditions and prostate cancer treatment-related side effects. Dr. Dieli-Conwright will explore this topic in more detail on the May 14 virtual symposium, hosted by MPCC. Click here to learn more about the Massachusetts Prostate Cancer Coalition.
Thanks to Adam Feldman, MD, PH, for discussing “Prostate Cancer Detection: Past, Present and Future.” Dr. Feldman is a urologic oncologist at the Massachusetts General Hospital Department of Urology. Director of the Combined Harvard Fellowship Program in Urologic Oncology and Director of Research for the Department of Urology at MGH, he will be presenting on this topic at the May 14 virtual symposium, hosted by MPCC. Click here to learn more about the Massachusetts Prostate Cancer Coalition.
Thanks to Dr. Marianne Brandon, clinical psychologist and diplomat in sex therapy, for this interview on “Sex and Intimacy after Prostate Cancer,” in which she discusses this topic in the broader context of intimacy and sexuality. Click here to learn more about the Massachusetts Prostate Cancer Coalition.
Thanks to Dr. Mark Pomerantz, a medical oncologist at the Dana-Farber Cancer Institute, for today’s interview. In this podcast he discusses “Genetics and Prostate Cancer” – highlighting recent discoveries and changes in the field of genetics and how they apply to prostate cancer specifically. Click here to learn more about the Massachusetts Prostate Cancer Coalition.
Thanks to Lorelei Mucci, ScD, MPH, for this interview discussing “The State of Evidence behind Lifestyle and Diet for Prostate Cancer Patients.” Dr. Mucci is the Director of the Cancer Epidemiology and Cancer Prevention Program in the Department of Epidemiology at the Harvard T.H. Chan School of Public Health (HSPH). This podcast is based on her presentation at the May 15, 2020 MPCC Virtual Symposium. Click here to learn more about the Massachusetts Prostate Cancer Coalition.
Welcome to Prostate Cancer & You, a series of podcasts produced by the Massachusetts Prostate Cancer Coalition.Today’s podcast features Dr. Jairam Eswara from St. Elizabeth’s Medical Center in Boston discussing “Signs, Symptoms and Treatment Options for Erectile Dysfunction and Male Stress Urinary Incontinence Post Prostate Cancer.”